Marilyn J. England - Concepedia

Author

Marilyn J. England

United States Army Medical Research Institute of Infectious Diseases

Also Known As

M J England, M. England, MARILYN J. ENGLAND, Marilyn England, Marilyn J England, Marilyn J. England

Publications

563

Citations

H-Index

Concepts

All Affiliations

United States Army Medical Research Institute of Infectious Diseases

About

Marilyn J. England is an author at United States Army Medical Research Institute of Infectious Diseases specializing in medicine, immunology, and infection control.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	12	12	408
2	Immunology	10	10	372
3	Microbiology	5	5	130
4	Engineering	2	2	65
5	Allergy	2	2	60

Marilyn J. England

Publications

524

Citations

H-Index

Page 1

	Year	Citations
In Vitro Antibiotic Susceptibilities of <i>Burkholderia mallei</i> (Causative Agent of Glanders) Determined by Broth Microdilution and E-Test Henry S. Heine, Marilyn J. England, David M. Waag, Antimicrobial Agents and Chemotherapy	2001	75
Comparative efficacy and immunogenicity of Q fever chloroform:methanol residue (CMR) and phase I cellular (Q-Vax) vaccines in cynomolgus monkeys challenged by aerosol David M. Waag, Marilyn J. England, Ralph F. Tammariello, Vaccine VaccinationMucosal VaccinationVaccine DevelopmentCynomolgus MonkeysImmunology	2002	59
Polysaccharide microarray technology for the detection of Burkholderia pseudomallei and Burkholderia mallei antibodies Narayanan Parthasarathy, David DeShazer, Marilyn J. England, Diagnostic Microbiology and Infectious Disease Molecular Diagnostic TechniquesEngineeringPathogen DetectionMedicineBioanalysis	2006	53
Comparative efficacy of a Coxiella burnetii chloroform:methanol residue (CMR) vaccine and a licensed cellular vaccine (Q-Vax) in rodents challenged by aerosol David M. Waag, Marilyn J. England, M. Louise M. Pitt Vaccine VaccinationCoxiella Burnetii ChloroformAllergyImmunologyToxicology	1997	48
Validation of an enzyme immunoassay for serodiagnosis of acute Q fever David M. Waag, Jeffrey D. Chulay, Thomas J. Marrie, European Journal of Clinical Microbiology & Infectious Diseases Pathogen DetectionPathogenesisImmunologySerologic TestingPathogen Characterization	1995	42
Cell-mediated and humoral immune responses after vaccination of human volunteers with the live vaccine strain of Francisella tularensis David M. Waag, Kelly T. McKee, Gunnar Sandström, Clinical and Diagnostic Laboratory Immunology	1995	41
Low-Dose Priming before Vaccination with the Phase I Chloroform-Methanol Residue Vaccine against Q Fever Enhances Humoral and Cellular Immune Responses to<i>Coxiella burnetii</i> David M. Waag, Marilyn J. England, C R Bolt, Clinical and Vaccine Immunology VaccinationVaccine DevelopmentImmunologyVaccine TestingLow-dose Priming	2008	39
Monoclonal Antibodies Passively Protect BALB/c Mice against <i>Burkholderia mallei</i> Aerosol Challenge Sylvia R. Treviño, Amy R. Permenter, Marilyn J. England, Infection and Immunity Laboratory ImmunologyMedicinePathogenesisImmunologyHumoral Response	2006	35
Cell-mediated and humoral immune responses induced by scarification vaccination of human volunteers with a new lot of the live vaccine strain of Francisella tularensis David M. Waag, A. Galloway, Gunnar Sandström, Journal of Clinical Microbiology ImmunologyScarification VaccinationVaccine TargetNew LotInfection Control	1992	32
Immunogenicity of a new lot of<i>Francisella tularensis</i>live vaccine strain in human volunteers David M. Waag, Gunnar Sandström, Marilyn J. England, FEMS Immunology & Medical Microbiology ImmunologyImmunodominanceScarification VaccinationImmunotherapyBacterial Pathogens	1996	29

Page 1